ABSTRACT
[...]of the ongoing pandemic, members met virtually throughout the 2020-2021 academic year to begin developing a framework and plan to address each of the 4 charges. CHARGE 2 SUBGROUP Background As the COVID-19 pandemic unfolded in the United States (US) in 2020, unprecedented federal expansion of scope of practice ("Scope") for pharmacists has been implemented by the US Department of Health and Human Services (DHHS) via the PREP Act. While the federal government has covered the cost of the vaccines and has provided supplemental funding to support access during the COVID-19 pandemic, payment for advanced patient care services provided by pharmacists in the future will be necessary for these services to be sustainable. CPAs * Continue to support the model that allows all licensed pharmacists with appropriate training to participate in CPAs, and does not restrict participation to subset of licensed pharmacists * Continue supporting the population model of CPAs which increases patient access and does not add undue regulatory burden to the process * Discourage use of patient-specific CPAs in meeting public health needs o Patient-specific CPAs are ineffective during a public health emergency * Encourage state boards of pharmacy to outline